- Title
- Rationale for the Use of Combination Injectable Therapy in Patients With Type 2 Diabetes Who Have High A1C (≥9%) and/or Long Duration (>8 Years): Executive Summary
- Creators
- Vivian A. Fonseca - Tulane UniversityMinisha Sood - Fifth Avenue Endocrinology, New York, NY.Rodolfo J. Galindo - Emory University
- Publication Details
- Clinical diabetes : a publication of the American Diabetes Association, Vol.39(2)
- Comment
- LR: 20220420; GR: K23 DK123384/DK/NIDDK NIH HHS/United States; GR: U54 GM104940/GM/NIGMS NIH HHS/United States; JID: 8406985; 2021/05/14 06:55 [entrez]; 2021/05/15 06:00 [pubmed]; 2021/05/15 06:01 [medline]; AID: CD200121 [pii]; ppublish
- ISBN
- 0891-8929; 1945-4953; 0891-8929
- Academic Unit
- UMMG Department of Medicine; Miller School of Medicine
- Language
- English
- Resource Type
- Journal article
- Record Identifier
- 991031816800302976
Journal article
Rationale for the Use of Combination Injectable Therapy in Patients With Type 2 Diabetes Who Have High A1C (≥9%) and/or Long Duration (>8 Years): Executive Summary
Clinical diabetes : a publication of the American Diabetes Association, Vol.39(2)
2021
Metrics
5 Record Views